Pfizer (NYSE: PFE) announced a multi-year collaboration with GlaxoSmithKline (NYSE: GSK) on the development of a next-generation equipment design, building ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Pfizer Announces Collaboration with GSK on Next-Generation Design of Portable, Continuous, Miniature and Modular (PCMM) Oral Solid Dose Development and Manufacturing UnitsOctober 29, 2015 8:01 AM Pfizer needs a big deal, analysts say; Allergan 'makes sense'October 29, 2015 7:39 AM